लखनऊ: CSIR स्टार्टअप कॉन्क्लेव में भारतीय हर्बल दवाओं ने लूटी वाहवाही, डायबिटीज रिवर्सल में हैं कारगर, 2025

Information on this website is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professionals. This website is meant for use by Indian residents only.